Tandem autologous stem cell transplantation in high-risk de novo multiple myeloma: final results of the prospective and randomized IFM 99-04 protocol-Reference-Cited by-同舟云学术

Tandem autologous stem cell transplantation in high-risk de novo multiple myeloma: final results of the prospective and randomized IFM 99-04 protocol

Published:2005-12-22 Issue:1 Volume:107 Page:397-403
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:Blood

Author:

Moreau Philippe,Hullin Cyrille,Garban Frédéric,Yakoub-Agha Ibrahim,Benboubker Lotfi,Attal Michel,Marit Gérald,Fuzibet Jean-Gabriel,Doyen Chantal,Voillat Laurent,Berthou Christian,Ketterer Nicolas,Casassus Philippe,Monconduit Mathieu,Michallet Mauricette,Najman Albert,Sotto Jean-Jacques,Bataille Régis,Harousseau Jean-Luc

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Reference25 articles.

1. A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma

2. High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple Myeloma

3. Comparison of 200 mg/m2 melphalan and 8 Gy total body irradiation plus 140 mg/m2 melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergroupe Francophone du Myelome 9502 randomized trial

4. Single versus Double Autologous Stem-Cell Transplantation for Multiple Myeloma

5. Treatment of multiple myeloma

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Daratumumab, carfilzomib, lenalidomide, and dexamethasone with tandem transplant for high-risk newly diagnosed myeloma;Blood;2024-05-16

2. Introduction to Multiple Myeloma and Multiple Myeloma Bone Disease;Metastatic Bone Disease;2024

3. Chromosome 1q21 abnormalities in multiple myeloma;Blood Cancer Journal;2021-04

4. MUKnine OPTIMUM protocol: a screening study to identify high-risk patients with multiple myeloma suitable for novel treatment approaches combined with a phase II study evaluating optimised combination of biological therapy in newly diagnosed high-risk multiple myeloma and plasma cell leukaemia;BMJ Open;2021-03

5. Long-term survival of 1338 MM patients treated with tandem autologous vs. autologous-allogeneic transplantation;Bone Marrow Transplantation;2020-04-14